Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Potential New Target For Treatment of Melanoma Identified | |
|
| |
Researchers have identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers.
Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells. But they found, in melanoma, Panx1 is over-produced to a pathological level. The researchers also discovered that if you reduce it or knock it down, the cell becomes more normal. The research is published in the August 17th issue of the Journal of Biological Chemistry.
Malignant melanoma only accounts for four per cent of all skin cancers and yet, it's responsible for 79% of skin cancer-related deaths. The World Health Organization says there are 200-thousand cases of melanoma diagnosed each year and 65 thousand melanoma-related deaths (2000 statistics).
"We think this over-production of Panx1, enables the melanoma to become very aggressive. The cells have these extra Panx1 channels and they can leave the primary tumor and invade other tissues," explains Laird, a Professor in the Department of Anatomy and Cell Biology, and Canada Research Chair in Gap Junctions and Disease. "And when you find a protein that is highly up-regulated in a disease cell such as a melanoma, the question becomes, is there therapeutic value in targeting a drug to that protein to reduce its production or block its function. Would that be an effective treatment?"
"We now want to correlate our discovery to patient samples using the human melanoma bank through our collaboration with Dr. Muriel Brackstone and other clinicians at the London Health Sciences Centre, to see if this is a cancer marker," says Penuela, a Postdoctoral Fellow working in the Laird lab. "So if a melanoma lesion has a lot of this protein, it might be a tool for prognosis, in saying this is more advanced, or going to be highly metastatic. And because it's on the skin, it would be more accessible for treatment." Penuela suggests potential treatment might be in the form of a topical medication to use on melanoma lesions.
The scientists also worked with David Litchfield and John Lewis and their teams at Schulich Medicine & Dentistry and the London Regional Cancer Program on this research. It was funded through the Canadian Institutes of Health Research. The Laird laboratory recently received a $200,000 Innovation Grant from the Canadian Cancer Society Research Institute to further its studies on Panx1.
Source-Eurekalert
| |
|
|
 Comment & Contribute
|
Related Links
Melanoma
Melanoma is the most dangerous type of skin cancer. It is a cancer that develops in melanocytes, cells which produce a skin pigment called ...
Vemurafenib Improves Survival in Advanced Malignant Melanoma
A new drug, vemurafenib, has recently been approved by the European Union for use in patients with advanced malignant melanoma with BRAF ...
Skin Cancer
Latest information on skin cancer, skin cancer types, risk factors and causes. Aspects related to skin cancer symptoms, diagnosis, treatment and ...
Cancer Related News
India Gets Advanced Breast Cancer Detecting Machine
In the national capital, an advanced digital breast cancer detecting machine with the capability to see the lesions in breasts with much more clarity ...
New Method can Help Distinguish Pancreatic Cancer from Pancreatitis
In a promising development that could help improve the accuracy of pancreatic cancer diagnosis, researchers at Mayo Clinic have come up with a new ...
Link Between Agent Orange Exposure and Prostate Cancer
A new study has now linked the exposure to Agent Orange and lethal forms of prostate cancer among the US Veterans. Published early online in ...
Tumour Growth Mechanism Goes a Step Further
New study suggests that loss of a particular tumour-suppressing protein causes abnormal growth of tumours of the brain and nervous system. ...
Link Between Skin Cancer and Lower Risk of Alzheimer's Disease Identified
According to a recent study people who have skin cancer are at a reduced risk of developing Alzheimer's disease. The link does not apply to melanoma, ...
Molecular Profiling Timely for Tailoring Therapy Shown By First Prospective Trial
Patients, and their physicians, are eager to jump into next-era cancer care analysis of an individual's tumor to find and target genetic mutations ...
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Melanoma
Complete Medindia Resources
|
| News Categories: |
| » | Health Campaigners Hail Brave Angelina Jolie's Mastectomy Revelation |
| » | Angelina Jolie's Breast Removal Surgery Boosts Cancer Awareness, Experts Advise Caution |
| » | Shakira Having Sleepless Nights During Pregnancy |
| » | Belgian Nobel Laureate Christian De Duve Dies |
| » | Sherri Shepherd Owes Her Life to Diabetes |
| More Celebrity News | |
|
Ask an Expert
